A new study in The Lancet has suggested that people benefit from taking the popular cholesterol busting drug Simvastatin regardless of the base levels of LDL cholesterol (the bad sort) and C-reactive protein (CRP) – a marker for systemic inflammation and associated with cardiovascular risk...